SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-24-000085
Filing Date
2024-05-03
Accepted
2024-05-03 08:43:48
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1714740220.html 4  
1 FORM 4 wk-form4_1714740220.xml 4 6062
  Complete submission text file 0001479290-24-000085.txt   7553
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Coric Vlad (Reporting) CIK: 0001704317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 24910937